Jan Braess

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Klaus H. Metzeler, Tobias Herold, Maja Rothenberg‐Thurley et al. · Blood · 2016 · 523 citations · Full text

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield et al. · Blood · 2008 · 445 citations · Full text

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach et al. · Journal of Clinical Oncology · 2008 · 337 citations

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

Utz Krug, Christoph Röllig, Anja Koschmieder et al. · The Lancet · 2010 · 302 citations

Hematological Malignancy, Prognostic Evaluation, Medicine +12

Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome

Annika Dufour, Friederike Schneider, Klaus H. Metzeler et al. · Journal of Clinical Oncology · 2009 · 292 citations · Full text